Potential Use of 1,25-Dihydroxycholecalciferol for Prevention of Parturient Paresis

38Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Twelve cows, at least third parity, were assigned randomly to either a control or treatment group. Treated cows received .4 mg of the vitamin D metabolite, 1,25-dihydroxycholecalciferol intramusculary in 5 ml corn oil. Intramuscular injections were started 5 days before predicted calving with reinjections every 5 days until calving. Incidence of parturient paresis was 0 and 33% (2 of 6) in the treated and control groups. Response to treatment was rapid with elevated calcium in serum approximately 12 h postinjection. Treatment maintained or elevated calcium and phosphorus concentrations in serum during the critical period, 24 h pre- to 48 h postpartum, when milk fever is most likely to occur. There was, however, no significant difference between treatments at 72 h postpartum. Based on these observations 1,25-dihydroxycholecalciferol holds promise as a preventative of parturient paresis; however, further studies are needed on application and safety. © 1979, American Dairy Science Association. All rights reserved.

Cite

CITATION STYLE

APA

Gast, D. R., Horst, R. L., Jorgensen, N. A., & DeLuca, H. F. (1979). Potential Use of 1,25-Dihydroxycholecalciferol for Prevention of Parturient Paresis. Journal of Dairy Science, 62(6), 1009–1013. https://doi.org/10.3168/jds.S0022-0302(79)83364-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free